NIH study uncovers new mechanism of action for class of chemotherapy drugs

National Institutes of Health (NIH) researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors. They have also identified differences in the toxic capabilities of three drugs in this class which are currently being tested in clinical trials.

Read more View All News

This page was last updated on Friday, January 21, 2022